Regeneron (RGO) Stock Forecast & Price Target

3 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

RGO Analyst Ratings

Moderate Buy

14 Buy

7 Hold

0 Sell

Based on 21 analysts giving stock ratings to

Regeneron

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

RGO Stock 12 Month Forecast

Average Price Target

€718.98

▲(25.19% Upside)

Based on 21 Wall Street analysts offering 12 month price targets for Regeneron in the last 3 months. The average price target is €718.98 with a high forecast of €893.36 and a low forecast of €555.96. The average price target represents a 25.19% change from the last price of €574.30.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"466":"€466","573":"€573","680":"€680","787":"€787","894":"€894"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":893.3597365,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€893.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":718.9831850666666,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€718.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":555.96465155,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€555.96</span>\n  </div></div>","useHTML":true}}],"tickPositions":[466,573,680,787,894],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,641.2,660.5969028076923,679.9938056153846,699.390708423077,718.7876112307692,738.1845140384615,757.5814168461538,776.9783196538463,796.3752224615384,815.7721252692309,835.169028076923,854.5659308846155,873.9628336923078,{"y":893.3597365,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,641.2,647.1833219282051,653.1666438564102,659.1499657846153,665.1332877128206,671.1166096410257,677.0999315692308,683.0832534974359,689.066575425641,695.0498973538461,701.0332192820513,707.0165412102564,712.9998631384615,{"y":718.9831850666666,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,641.2,634.6434347346154,628.0868694692308,621.5303042038462,614.9737389384616,608.417173673077,601.8606084076923,595.3040431423077,588.7474778769231,582.1909126115385,575.6343473461538,569.0777820807692,562.5212168153846,{"y":555.96465155,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":467.415,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 57,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":498.013,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":521.121,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 59,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":566.54,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":653.21,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":659.991,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":637.852,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":669.369,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":667.571,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":573.916,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":519,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":552.5,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":641.2,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€893.36

Average Price Target€718.98

Lowest Price Target€555.96

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Eliana Merle

Barclays

€795.35

Buy

38.49%

Upside

Reiterated

08/05/26

Barclays Keeps Their Buy Rating on Regeneron (REGN)

Chris Schott

J.P. Morgan

€737.24→€780.61

Buy

35.92%

Upside

Reiterated

08/04/26

J.P. Morgan Sticks to Its Buy Rating for Regeneron (REGN)

Yatin Suneja

Guggenheim

€867.34→€893.36

Buy

55.56%

Upside

Reiterated

08/03/26

Regeneron price target raised to $1,030 from $1,000 at GuggenheimRegeneron price target raised to $1,030 from $1,000 at Guggenheim

Geoff Meacham

Citi

€607.14→€641.83

Hold

11.76%

Upside

Reiterated

08/03/26

Regeneron price target raised to $740 from $700 at CitiRegeneron price target raised to $740 from $700 at Citi

Gregory Renza

Truist Financial

€666.98→€669.59

Buy

16.59%

Upside

Reiterated

07/31/26

Truist Financial Remains a Buy on Regeneron (REGN)

Mohit Bansal

Wells Fargo

€607.14→€650.5

Hold

13.27%

Upside

Reiterated

07/31/26

Regeneron price target raised to $750 from $700 at Wells FargoRegeneron price target raised to $750 from $700 at Wells Fargo

Terence Flynn

Morgan Stanley

€633.16→€657.44

Hold

14.48%

Upside

Reiterated

07/31/26

Morgan Stanley Keeps Their Hold Rating on Regeneron (REGN)

Evan Seigerman

BMO Capital

€633.16→€693.87

Buy

20.82%

Upside

Reiterated

07/31/26

BMO Capital Reaffirms Their Buy Rating on Regeneron (REGN)

Louise Chen

Scotiabank

€667.85

Hold

16.29%

Upside

Reiterated

07/31/26

Scotiabank Sticks to Their Hold Rating for Regeneron (REGN)

Brian Skorney

Robert W. Baird

€643.57→€660.05

Hold

14.93%

Upside

Reiterated

07/31/26

Regeneron price target raised to $761 from $742 at BairdRegeneron price target raised to $761 from $742 at Baird

Tyler Van Buren

TD Cowen

€832.65

Buy

44.98%

Upside

Reiterated

07/30/26

Analysts Are Bullish on Top Healthcare Stocks: AbbVie (ABBV), Regeneron (REGN)

Brian Abrahams

RBC Capital

€603.67→€639.23

Hold

11.31%

Upside

Assigned

07/30/26

RBC Capital Reaffirms Their Hold Rating on Regeneron (REGN)

Salveen Richter

Goldman Sachs

€836.98→€843.05

Buy

46.80%

Upside

Reiterated

07/30/26

Goldman Sachs Keeps Their Buy Rating on Regeneron (REGN)

Tazeen Ahmad

Bank of America Securities

€742.44→€772.8

Buy

34.56%

Upside

Reiterated

07/30/26

Regeneron: Strong Execution, Growth Visibility and Pipeline Catalysts Drive Price Target Increase to $891

Carter Gould

Cantor Fitzgerald

€650.5→€689.53

Buy

20.07%

Upside

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX), Regeneron (NASDAQ: REGN) and PTC Therapeutics (NASDAQ: PTCT)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Eliana Merle

Barclays

€795.35

Buy

38.49%

Upside

Reiterated

08/05/26

Barclays Keeps Their Buy Rating on Regeneron (REGN)

Chris Schott

J.P. Morgan

€737.24→€780.61

Buy

35.92%

Upside

Reiterated

08/04/26

J.P. Morgan Sticks to Its Buy Rating for Regeneron (REGN)

Yatin Suneja

Guggenheim

€867.34→€893.36

Buy

55.56%

Upside

Reiterated

08/03/26

Regeneron price target raised to $1,030 from $1,000 at GuggenheimRegeneron price target raised to $1,030 from $1,000 at Guggenheim

Geoff Meacham

Citi

€607.14→€641.83

Hold

11.76%

Upside

Reiterated

08/03/26

Regeneron price target raised to $740 from $700 at CitiRegeneron price target raised to $740 from $700 at Citi

Gregory Renza

Truist Financial

€666.98→€669.59

Buy

16.59%

Upside

Reiterated

07/31/26

Truist Financial Remains a Buy on Regeneron (REGN)

Mohit Bansal

Wells Fargo

€607.14→€650.5

Hold

13.27%

Upside

Reiterated

07/31/26

Regeneron price target raised to $750 from $700 at Wells FargoRegeneron price target raised to $750 from $700 at Wells Fargo

Terence Flynn

Morgan Stanley

€633.16→€657.44

Hold

14.48%

Upside

Reiterated

07/31/26

Morgan Stanley Keeps Their Hold Rating on Regeneron (REGN)

Evan Seigerman

BMO Capital

€633.16→€693.87

Buy

20.82%

Upside

Reiterated

07/31/26

BMO Capital Reaffirms Their Buy Rating on Regeneron (REGN)

Louise Chen

Scotiabank

€667.85

Hold

16.29%

Upside

Reiterated

07/31/26

Scotiabank Sticks to Their Hold Rating for Regeneron (REGN)

Brian Skorney

Robert W. Baird

€643.57→€660.05

Hold

14.93%

Upside

Reiterated

07/31/26

Regeneron price target raised to $761 from $742 at BairdRegeneron price target raised to $761 from $742 at Baird

Tyler Van Buren

TD Cowen

€832.65

Buy

44.98%

Upside

Reiterated

07/30/26

Analysts Are Bullish on Top Healthcare Stocks: AbbVie (ABBV), Regeneron (REGN)

Brian Abrahams

RBC Capital

€603.67→€639.23

Hold

11.31%

Upside

Assigned

07/30/26

RBC Capital Reaffirms Their Hold Rating on Regeneron (REGN)

Salveen Richter

Goldman Sachs

€836.98→€843.05

Buy

46.80%

Upside

Reiterated

07/30/26

Goldman Sachs Keeps Their Buy Rating on Regeneron (REGN)

Tazeen Ahmad

Bank of America Securities

€742.44→€772.8

Buy

34.56%

Upside

Reiterated

07/30/26

Regeneron: Strong Execution, Growth Visibility and Pipeline Catalysts Drive Price Target Increase to $891

Carter Gould

Cantor Fitzgerald

€650.5→€689.53

Buy

20.07%

Upside

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX), Regeneron (NASDAQ: REGN) and PTC Therapeutics (NASDAQ: PTCT)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

TNYATenaya Therapeutics

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Regeneron

3 Months

Yatin SunejaGuggenheim

Success Rate

12/16 ratings generated profit

Average Return

+4.17%

Copying Yatin Suneja's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +4.17% per trade.

1 Year

Yatin SunejaGuggenheim

Success Rate

14/16 ratings generated profit

Average Return

+20.03%

Copying Yatin Suneja's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +20.03% per trade.

2 Years

Yatin SunejaGuggenheim

Success Rate

11/16 ratings generated profit

Average Return

+15.99%

Copying Yatin Suneja's trades and holding each position for 2 Years would result in 68.75% of your transactions generating a profit, with an average return of +15.99% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RGO Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, RGO has received 20 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. RGO average Analyst price target in the past 3 months is 718.98.

Each month's total comprises the sum of three months' worth of ratings.

RGO Financial Forecast

RGO Earnings Forecast

Next quarter’s earnings estimate for RGO is €13.77 with a range of €11.21 to €15.31. The previous quarter’s EPS was €12.38. RGO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.32% of the time in the same period. In the last calendar year RGO has Performed in-line its overall industry.

RGO Sales Forecast

Next quarter’s sales forecast for RGO is €3.92B with a range of €3.64B to €4.13B. The previous quarter’s sales results were €3.72B. RGO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 31.16% of the time in the same period. In the last calendar year RGO has Performed in-line its overall industry.

RGO Stock Forecast FAQ

What is DE:RGO’s average 12-month price target, according to analysts?

Based on analyst ratings, Regeneron’s 12-month average price target is 718.98.

What is DE:RGO’s upside potential, based on the analysts’ average price target?

Regeneron has 25.19% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Regeneron a Buy, Sell or Hold?

Regeneron has a consensus rating of Moderate Buy, which is based on 14 buy ratings, 7 hold ratings and 0 sell ratings.

What is Regeneron’s share price target?

The average share price target for Regeneron is 718.98. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €893.36 ,and the lowest forecast is €555.96. The average share price target represents 25.19% Increase from the current price of €574.3.

What do analysts say about Regeneron?

Regeneron’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 21 Wall Streets Analysts.

How can I buy shares of Regeneron?

To buy shares of DE:RGO, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Regeneron (RGO) Stock Forecast & Price Target

RGO Analyst Ratings

RGO Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Regeneron

RGO Analyst Recommendation Trends

RGO Financial Forecast

RGO Earnings Forecast

RGO Sales Forecast

RGO Stock Forecast FAQ

Detailed List of Analyst Forecasts